Tirzepatide
Dual GIP/GLP-1 Receptor Agonist - Proven effective for medical weight loss at an affordable price
Join 4MM+ happy patients • Rated ★★★★★ 4.8/5
What is Tirzepatide?
Tirzepatide is the first and only dual GIP/GLP-1 receptor agonist approved for weight management. By activating two key hormone pathways instead of one, tirzepatide delivers superior weight loss results compared to semaglutide-based medications.
Clinical trials show tirzepatide users lose an average of 20-22% of their body weight - nearly 50% more than patients taking semaglutide. This makes it the most effective weight loss medication currently available.
How Tirzepatide Works
Dual Hormone Action
Activates both GIP and GLP-1 receptors for enhanced appetite suppression and metabolic benefits.
Superior Weight Loss
Clinical trials show up to 22% weight loss - significantly more than single-action GLP-1 medications.
Improved Metabolism
Better blood sugar control and insulin sensitivity compared to semaglutide alone.
Benefits of Tirzepatide
Most Effective Treatment Available
Clinical trials show average 20-22% body weight loss - nearly double that of semaglutide
Dual-Action Mechanism
Works on both GIP and GLP-1 receptors for superior appetite control and metabolic benefits
Faster Results
Patients typically see weight loss results more quickly than with semaglutide alone
Once-Weekly Convenience
Simple weekly injection that fits seamlessly into your routine
Comprehensive Health Benefits
Improves blood sugar, cholesterol, blood pressure, and other metabolic markers
FDA-Approved Safety
Backed by extensive clinical research and FDA approval
Tirzepatide vs Semaglutide
Compare the two leading GLP-1 medications
| Feature | Tirzepatide | Semaglutide |
|---|---|---|
| Weight Loss Results | 20-22% average | 15% average |
| Mechanism of Action | Dual GIP/GLP-1 | GLP-1 only |
| Monthly Cost | $225 | $155 |
| Source | US Compounding Pharmacy | US Compounding Pharmacy |
| Dosing Schedule | Once weekly | Once weekly |
| FDA Approval | Yes | Yes |
Ready to Start Your Weight Loss Journey?
Get started with tirzepatide today. Complete a brief online consultation and get your prescription.
Get Started NowJoin 4MM+ happy patients • Rated ★★★★★ 4.8/5
Frequently Asked Questions
Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide only targets GLP-1. This dual action makes tirzepatide significantly more effective, with patients losing an average of 20-22% of body weight compared to 15% with semaglutide.
Many patients find the additional effectiveness worth the extra $70/month. Tirzepatide delivers nearly 50% more weight loss on average, helping you reach your goals faster and with better long-term results.
Side effects are similar to semaglutide - nausea, diarrhea, and constipation are most common. These are typically mild and improve as your body adjusts. We start with a low dose and gradually increase to minimize side effects.
Most patients notice appetite suppression within the first week. Visible weight loss typically starts within 4-6 weeks, with maximum effects after several months of treatment.
Yes, many patients upgrade to tirzepatide for enhanced results. Your care team will help you transition safely and adjust dosing appropriately.